EU Projects

EU Projects

Sub channels

Media pages

<< 1... 18 19 20 21 22 25 >>

EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multi-centre study

Update on pancreatic and liver disease in cystic fibrosis

Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension - results from a large European multicentre randomised controlled trial

REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH)

Long-term outcomes in incident pulmonary arterial hypertension (PAH) patients initiated with triple combination therapy including parenteral prostacyclin (PGI2)

Long-term outcomes with initial triple oral therapy in pulmonary arterial hypertension (PAH): Insights from TRITON

Genetic and non-genetic risk factors for severe pulmonary sarcoidosis

Update on management of lung infection in cystic fibrosis

Combination therapy with sotatercept analog RAP-011 is superior to sildenafil alone in severe experimental PAH and RAP-011 benefits persist after treatment cessation

Pathogenesis of pulmonary fibrosis in sarcoidosis

<< 1... 18 19 20 21 22 25 >>